84
Views
2
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Promotion of cancer metastasis: candidate validation using an iTRAQ-based approach

&
Pages 321-323 | Published online: 09 Jan 2014

References

  • Ghosh D, Li Z, Tan XF, Lim TK, Mao Y, Lin Q. iTRAQ based quantitative proteomics approach validated the role of calcyclin binding protein (CacyBP) in promoting colorectal cancer metastasis. Mol. Cell Proteomics 12(7), 1865–1880 (2013).
  • Ghosh D, Yu H, Tan XF et al. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines. J. Proteome Res. 10, 4373–4387 (2011).
  • Glen A, Evans CA, Gan CS et al. Eight-plex iTRAQ analysis of variant metastatic human prostate cancer cells identifies candidate biomarkers of progression: an exploratory study. Prostate 70(12), 1313–1332 (2010).
  • Kilan´czyk E, Gwoz´dzin´ski K, Wilczek E, Filipek A. Up-regulation of CacyBP/SIP during rat breast cancer development. Breast Cancer doi:10.1007/s12282-012-0399-1 (2012) (Epub ahead of print).
  • Hawn MT, Umar A, Carethers JM et al. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res. 55(17), 3721–3725 (1995).
  • Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36(12), 4562–4569 (1976).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.